̩ɽҽѧԺҽѧԺרҵܣѧ벡ѧ

(0) (0) վС ѿ 2016-07-27 11:07:18 Ķ(0)
ѧ벡ѧ̬̽ܵѧơѧ齨1974꣬2000걻˶ʿѧλȨ㣬2005걻ѧУ׼Ϊ̩ɽҽѧԺصѧƣѧƾȫԱĹͬŬõ˳ķչ

ѧƾص㽨裬2008걻̩ɽѧ߸λγӵн7ˣ5ˣ˶ʿʦ9ˣʦʵ˶ʿвʿѧλ6ˡ̩ɽѧ߸λƸ1Уʦ3

ѧƵ˲оѧ衶ѧѧǻ֯ѧѧѧ߼ѧѪܲѧʵѧȿγ̡ѧѧŶ2009걻ΪʡѧŶӣ2008겡ѧγ̱ΪʡƷγ̡2009겡ѧγ̱ΪʡƷγ̡2010겡ѧγ̲ҼƷγ̽衣

õĽѧп⣨ϵĿ⣩

ؿӲüоɽʡ2007-20096򣩣ӲƽϸֳоɽʡȻѧ2002-20056򣩣佺ڳȱѪٹעеõо̩ɽҽѧԺ2007-20081򣩣̩ɽ佺ͪVEC𤸽ӱPػо̩ɽҽѧԺ 2005-20071ԪǿԱϿչ̲֪ʶͷѵйģ2008.102009.056򣩡֬ģƤϸʡȻѧصĿ 2008-2011⸺ˣ7򣩣ܶ֬׹ܵķӻɽʡ̩ɽѧר2009-2013⸺ 100򣩣֬ת˵׵ܺͲ壨ר2008-2012⸺ˣ50򣩡ĸҽѧרʵѧģʽǿҽѧٴʵоѧ2009-2011⸺ˣ0.3򣩡ٴҽѧʵʵѧϵоʵѧɽʡ2009-2012⸺ˣ3򣩡ɽʡߵҽѧչ״ҹвߵҽѧȽоѧɽʡ2006.01-2008.12⸺ˣ2.0򣩡ҽѧרҵʽϵȫҽѧ˲ţΰɽʡѧ“ʮһ”滮2008ص⣬2009.01-2010.12⸺ˣ1򣩡ѧʹѧѧϳЧƵĹʵΰɽʡѧо⣬⸺ˣ1򣩡ض֬꾲Ƥϸ˵ıãΰɽʡȻ⣬2008-2010⸺ˣ5򣩡޸ٰͪϸӰ죨 ̩пƼչƻĿ2008-2010⸺ˣ2򣩡

õĽϵĻ񽱣

ǿýѧءȫ߽ѧɽʡУѧɹȽɽʡһλ2005ȫ᳹ѧ١ȲѧˮƽɽʡУѧɹȽɽʡһλ2006ýѧϵͳڹǿƽѧеӦãɽʡУѧɹȽɽʡһλ2006縨ѧƽ̨ѧ廯ѧԴ輰ӦáҼѧɹȽһλ200521ٴҽѧרҵרѧݺͿγϵоʵɽʡѧɹȽһλ2005ԤҽѧѧϵĸPǿʵоɽʡѧɹȽһλ2007ҽѧ绥ʵƽ̨ĹӦáɽʡߵȽѧɹȽһλ2009ѧʹѧѧϳЧƵĹʵɽʡʡѧоɹȽһλ2009ٴҽѧרѧ״ѧĸ̽ɽʡҽѧĽһȽһλ2005ʴϸθоɽߵѧУгɹȽһλ2005θзʴϸķֲصֳϸ˿ԭBcl-2ĹϵѧоɽߵѧУгɹȽһλ2006

Ľ̲

ѧ֣磬ࣻѧʵָ磬ࣻѧӦ򵼡/ҽѧ⾫飬࣬ѧ磻ѧϰԲ⡷Ӣİ棩 磬ࣻѧ벡ѧӦ򵼡ͬôѧ磬ࣻҽѧѧʵ̡̳࣬磻ҽѧѧʵָ࣬磻ѧϰ⼯࣬ҽѧѧ磺ѧ࣬ȡ

ģ

SCI¼ģ

1 Rosuvastatin on apoAI secretion without affecting apolipoprotein A-II in HepG2 cells, Metabolism

2 Pioglitazong on apoAI production without affecting HDL protein and cholesterol ester removal in HepG2 cellsATVB

3 RD4F an apolipoprotein A-I mimetic peptide, inhibits aortic lesion macrophages and enhances HDL anti-inflammatory function in apolipoprotein E-null mice. CIRCULATION

4 RD4F an apolipoprotein A-I mimetic peptide, inhibits atherosclerosis in apolipoprotein E-null mice. CIRCULATION

5 Niacin inhibits LDL oxidation and redox-sensitive VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis.

ĿǰеʺĿ1ʡ20ʡ3귢ѧ100ƪкڿ80ƪ̲2α10ಿ
Ѿ0 鿴ȫ

ؼ

Ϣ

ƼϢ

ͷϢ